Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Charmacy Pharmaceutical Co., Ltd. has announced a board meeting scheduled for August 28, 2024, to discuss and approve the interim results for the first half of the year and to consider the declaration of an interim dividend. The meeting will also include public disclosure of the company’s financial performance. The notice, issued on August 16, 2024, includes a list of the company’s current executive and non-executive directors.
For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.